Age at primary BC diagnosis, menopausal status at primary BC diagnosis, histological grading of BC, different subtypes of BC (HR + /HER2-negative, triple negative, HER2-positive), and type of adjuvant and palliative treatments (endocrine therapy, endocrine therapy and chemotherapy, chemotherapy, anti-HER2-therapy). Here, ERBB2 is linked to breast cancer.